Pfizer Inc (NYSE:PFE)

50.68
Delayed Data
As of 4:00pm ET
 -1.20 / -2.31%
Today’s Change
38.82
Today|||52-Week Range
61.71
-14.17%
Year-to-Date
Investors Need Not Be Alarmed by Drug Patent Expirations
3:02pm / GuruFocus News - Paid Partner Content
Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response
Jun 27 / Zacks.com - Paid Partner Content
Company News for Jun 28, 2022
9:42am / Zacks.com - Paid Partner Content
3 Reasons to Buy Novavax and 1 to Sell
Jun 27 / MotleyFool.com - Paid Partner Content
Should You Invest in the Vanguard Health Care ETF (VHT)?
6:20am / Zacks.com - Paid Partner Content
Could This Be Moderna's Ticket to Long-Term Success?
Jun 27 / MotleyFool.com - Paid Partner Content
Is This Medical Therapeutics Company Worth Buying or a Major Risk?
5:56am / StockNews.com - Paid Partner Content
Why Sanofi May Be a Frontrunner in Endemic COVID-19
Jun 25 / MotleyFool.com - Paid Partner Content
How Pfizer Plans to Unlock Another Mass-Market Vaccine
Jun 27 / MotleyFool.com - Paid Partner Content
1 Green Flag for Moderna's Fall Vaccine Plan, and 1 Red Flag
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close51.88
Today’s open51.88
Day’s range50.41 - 51.96
Volume16,334,320
Average volume (3 months)26,853,513
Market cap$289.5B
Data as of 4:00pm ET, 06/28/2022

Growth & Valuation

Earnings growth (last year)+128.42%
Earnings growth (this year)+52.39%
Earnings growth (next 5 years)-2.70%
Revenue growth (last year)+93.97%
P/E ratio11.4
Price/Sales4.15
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-9.45-2.89%
ABBVAbbVie-0.65-0.42%
MRKMerck-2.16-2.29%
AZNAstraZeneca-0.56-0.84%
Data as of 4:25pm ET, 06/28/2022

Financials

Next reporting dateJuly 28, 2022
EPS forecast (this quarter)$1.79
Annual revenue (last year)$81.3B
Annual profit (last year)$22.1B
Net profit margin27.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts